DRUG · Unmapped registry intervention
Adjuvant Chemotherapy
Find medicine records ·
Find other trials using this name
Clinical trial
Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)
NCT01817192
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Radiographic surveillance
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
14-Gene Prognostic Assay
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedAdjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Razor Genomicslead sponsor
Encore Clinicalcollaborator
Mapped research locations
ParisFrance4MarseilleFrance2St LouisMissouri, United States1NashvilleTennessee, United States1SeattleWashington, United States1PittsburghPennsylvania, United States1Oklahoma CityOklahoma, United States1SacramentoCalifornia, United States1ToulouseFrance1LouisvilleKentucky, United States1LyonFrance1LexingtonKentucky, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01817192 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.